Effect of Rosiglitazone on ADMA in Critical Illness

Clinical trial NCT00409097 · UNKNOWN

Trial details

NCT number: NCT00409097
Sponsor: Amsterdam UMC, location VUmc
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Critical Illness Multiple Organ Failure

Start date: 2006-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.